editor, reviewer
154
edits
Changes
no edit summary
{{Drug
| name = carbamazepineCarbamazepine
| group = anticonvulsant
| type = Moodstabilizermoodstabilizer
| medscape = 1493
| drugscom = carbamazepine
| pubchem = 2554
| ATC = N03AF01
| metabolization = * Carbamazepine is principally metabolized by CYP3A4, and is a potent inducer of CYP1A2, CYP2C9, CYP3A4 and UDP-glucuronosyltransferases. | addition = | removal = | administration = OralO
| ctox = 13000
| ctox_ref = <ref name="ftktox">{{ftktox}}</ref>
| halflife = 8-72
| halflife_ref = <ref name="ftk">{{FTK|carbamazepine}}</ref>
| avail = 85-100
| avail_ref = <ref name="informatorium" >{{KNMP|carbamazepine}} </ref>| dose DDD = 1000| DDD DDD_ref = 800-1200<ref>{{WHOCC|N03AF01}}</ref>| dmax = <includeonly>| isswitch = 1</includeonly>
}}